Vaccine trial expanding to include young children in US, Canada

  • By cvbizz
  • March 16, 2021
  • 0
Share This Post!

One of the three companies currently administering COVID-19 vaccines in adults across the country has announced the expansion of a study testing their shot in children. In a news release issued Tuesday, Moderna announced its first participants in the KidCOVE study, the company’s vaccine trial for children ages 6 months to 12 years. The study will aim to determine the safety, tolerability and effectiveness of

PHP Code Snippets Powered By :